Olaparib for PAH: a Multicenter Clinical Trial
clinical trial
Press Enter · cited answer in seconds
0 sources
Summary
Olaparib for PAH: a Multicenter Clinical Trial is a clinical trial[1].
Key Facts
- Olaparib for PAH: a Multicenter Clinical Trial is in the country of a Multicenter Clinical Trial — country (P17): Canada[2].
- Olaparib for PAH: a Multicenter Clinical Trial's instance of is recorded as a Multicenter Clinical Trial — instance of (P31): clinical trial[3].
- Olaparib for PAH: a Multicenter Clinical Trial's start time is recorded as +2019-03-15T00:00:00Z[4].
- Olaparib for PAH: a Multicenter Clinical Trial's end time is recorded as +2021-02-15T00:00:00Z[5].
- Olaparib for PAH: a Multicenter Clinical Trial's sponsor is recorded as a Multicenter Clinical Trial — sponsor (P859): Laval University[6].
- Olaparib for PAH: a Multicenter Clinical Trial's main subject is recorded as a Multicenter Clinical Trial — main subject (P921): pulmonary hypertension, primary, 1[7].
- Olaparib for PAH: a Multicenter Clinical Trial's main subject is recorded as a Multicenter Clinical Trial — main subject (P921): arterial hypertension[8].
- Olaparib for PAH: a Multicenter Clinical Trial's number of participants is recorded as {'unit': '1', 'amount': '+20'}[9].
- Olaparib for PAH: a Multicenter Clinical Trial's title is recorded as Olaparib for Pulmonary Arterial Hypertension: a Multicenter Clinical Trial[10].
- Olaparib for PAH: a Multicenter Clinical Trial's short name is recorded as OPTION[11].
- Olaparib for PAH: a Multicenter Clinical Trial's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}[12].
- Olaparib for PAH: a Multicenter Clinical Trial's ClinicalTrials.gov ID is recorded as NCT03782818[13].
- Olaparib for PAH: a Multicenter Clinical Trial's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+75'}[14].
- Olaparib for PAH: a Multicenter Clinical Trial's research intervention is recorded as a Multicenter Clinical Trial — research intervention (P4844): olaparib[15].
- Olaparib for PAH: a Multicenter Clinical Trial's clinical trial phase is recorded as a Multicenter Clinical Trial — clinical trial phase (P6099): phase I clinical trial[16].
- Olaparib for PAH: a Multicenter Clinical Trial's research site is recorded as a Multicenter Clinical Trial — research site (P6153): University of Ottawa Skills and Simulation Centre[17].
- Olaparib for PAH: a Multicenter Clinical Trial's study type is recorded as a Multicenter Clinical Trial — study type (P8363): interventional study[18].